TMCnet News
Research and Markets: Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Pipeline Report 2015 - 37 Companies & 57 Drug ProfilesResearch and Markets (http://www.researchandmarkets.com/research/9rgs8z/clostridium) has announced the addition of the "Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease) and special features on late-stage and discontinued projects. The report enances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/9rgs8z/clostridium
View source version on businesswire.com: http://www.businesswire.com/news/home/20150721006219/en/ |
